erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Pancreatitis D010195 10 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Dyspnea D004417 10 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Pneumonia D011014 10 associated lipids
Osteitis D010000 10 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Rhinitis D012220 10 associated lipids
Tooth, Impacted D014095 9 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Griffith DP et al. Intravenous erythromycin facilitates bedside placement of postpyloric feeding tubes in critically ill adults: a double-blind, randomized, placebo-controlled study. 2003 Crit. Care Med. pmid:12544991
Hallstrom CK and Jacobs BR Optimal method of postpyloric tube placement still unclear. 2003 Crit. Care Med. pmid:12545040
Jain A et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. 2002 Dermatol. Online J. pmid:12546757
Sekteera W et al. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report. 2002 J Med Assoc Thai pmid:12549792
Busch DF et al. Activity of combinations of antimicrobial agents against Bacteroides fragilis. 1976 J. Infect. Dis. pmid:1254988
Haskell R Oral vesiculo-bullous lesions. 1976 J Laryngol Otol pmid:1254998
Oteo J et al. [Antibiotic resistance in 622 Streptococcus pneumoniae isolated from blood and cerebrospinal fluid in 33 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000)]. 2003 Enferm. Infecc. Microbiol. Clin. pmid:12550039
Hejzlar M et al. [Survey of the sensitivity of the strains Neisseria gonorrhoeae to antibioticas in the CSSR during 1957-1973 (authors transl)]. 1975 Zentralbl Bakteriol Orig A pmid:125512
Alós JI et al. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. 2003 J. Antimicrob. Chemother. pmid:12562699
Rastogi S et al. Effect of treatment for Chlamydia trachomatis during pregnancy. 2003 Int J Gynaecol Obstet pmid:12566185
Dumas L et al. [Perinatal interventions. The importance of convincing data]. 2002 Nov-Dec Infirm Que pmid:12567840
Wilkinson NW et al. The effect of erythromycin on bile excretion and proximal small bowel motility following divided gastric bypass surgery: a prospective randomized placebo-controlled trial. 2002 Obes Surg pmid:12568180
Hammerschmidt S et al. [Febrile respiratory infection and erythema in a 25-year-old man]. 2003 Dtsch. Med. Wochenschr. pmid:12571794
Tan S et al. Hazards of widespread use of erythromycin for preterm prelabour rupture of membranes. 2003 Lancet pmid:12573418
Takamura M et al. [Continuous low-dosage macrolide therapy in children with bronchial asthma]. 2001 Jpn J Antibiot pmid:12575408
Hozawa T [Evidence-based macrolide therapy for children with serous otitis media]. 2001 Jpn J Antibiot pmid:12575413
Idesaki M et al. [Effects of 14-membered ring macrolide on transcription factors in human bronchial epithelial cells]. 2001 Jpn J Antibiot pmid:12575415
Takeyama K et al. [Effect of macrolide antibiotics on MUC5AC production in human bronchial epithelial cells]. 2001 Jpn J Antibiot pmid:12575418
Shimizu T et al. [Effect of macrolide antibiotics on mucus secretion from cultured epithelial cells of nasal mucosa]. 2001 Jpn J Antibiot pmid:12575419
Shinkawa K et al. [Effects of erythromycin and clarithromycin on chloride channels in bronchial epithelial cells]. 2001 Jpn J Antibiot pmid:12575420
Aoki K et al. [Effects of macrolide antibiotics on LPS-induced neutrophil and macrophage activation]. 2001 Jpn J Antibiot pmid:12575422
Sasaki M et al. [Effect of 14-membered ring macrolides on heparanase mRNA expression in lung cancer cells]. 2001 Jpn J Antibiot pmid:12575430
Maeda K and Mikasa K [Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy]. 2001 Jpn J Antibiot pmid:12575432
Satoh H et al. Endobronchial actinomycosis and foreign body. 2003 Chest pmid:12576401
Chen SX et al. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives]. 2001 Yao Xue Xue Bao pmid:12579933
Massie RJ et al. Pertussis: adults as a source in healthcare settings. 2003 Med. J. Aust. pmid:12580755
Nikolaidis P et al. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates. 2002 J Chemother pmid:12583543
Esteban J et al. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. 2002 J Chemother pmid:12583544
Novelli A et al. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. 2002 J Chemother pmid:12583550
Lazarova TI et al. Synthesis of new 14-membered macrolide antibiotics via a novel ring contraction metathesis. 2003 Org. Lett. pmid:12583739
Tauch A et al. Insights into the genetic organization of the Corynebacterium diphtheriae erythromycin resistance plasmid pNG2 deduced from its complete nucleotide sequence. 2003 Plasmid pmid:12584002
Curtis LH et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. 2003 Am. J. Med. pmid:12586234
Baughman AL and Bisgard KM Need for equivalence testing of efficacy of alternative antibiotics for treatment of pertussis. 2003 Pediatr. Infect. Dis. J. pmid:12586986
Alfredson DA et al. Antimicrobial resistance and genomic screening of clinical isolates of thermophilic Campylobacter spp. from south-east Queensland, Australia. 2003 J. Appl. Microbiol. pmid:12588558
Maganti K et al. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. 2003 Am. J. Gastroenterol. pmid:12591038
Pestka S et al. Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. 1976 Antimicrob. Agents Chemother. pmid:1259386
Nichols RL et al. Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. 1973. 2000 Surg Infect (Larchmt) pmid:12594901
Sakushima A et al. Guaiacylglycerol-7'-O-methyl 8'-vanillic acid ether and related compounds from Boreava orientalis. Phytochem Anal pmid:12597255
Telithromycin: new preparation. A needless addition to the other macrolides. 2003 Prescrire Int pmid:12602373
KarakaÅŸ M et al. A case of bacillary angiomatosis presenting as leg ulcers. 2003 J Eur Acad Dermatol Venereol pmid:12602974
Grady R and Hayes F Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. 2003 Mol. Microbiol. pmid:12603745
Betriu C et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. 2003 Antimicrob. Agents Chemother. pmid:12604549
Vacher S et al. PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. 2003 Antimicrob. Agents Chemother. pmid:12604552
Pletz MW et al. ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate. 2003 Antimicrob. Agents Chemother. pmid:12604553
Neuhauser MM et al. In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae. 2003 Antimicrob. Agents Chemother. pmid:12604554
Lin E et al. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro. 2003 Antimicrob. Agents Chemother. pmid:12604560
Dinos GP et al. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. 2003 Mol. Pharmacol. pmid:12606769
Adam W et al. A highly chemoselective, diastereoselective, and regioselective epoxidation of chiral allylic alcohols with hydrogen peroxide, catalyzed by sandwich-type polyoxometalates: enhancement of reactivity and control of selectivity by the hydroxy group through metal-alcoholate bonding. 2003 J. Org. Chem. pmid:12608784
Scheinfeld NS et al. Macrolides in dermatology. 2003 Jan-Feb Clin. Dermatol. pmid:12609587
Thornton Spann C et al. Topical antimicrobial agents in dermatology. 2003 Jan-Feb Clin. Dermatol. pmid:12609591
Bingen E [Acute streptococcal sore throats in children, state of the present situation. Interview with Pr. E Bingen by Marie Solignac]. 2003 Presse Med pmid:12610476
Bourgeois N et al. In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis. 2003 J. Antimicrob. Chemother. pmid:12615884
Moodley P et al. Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management. 2003 Sex Transm Dis pmid:12616144
Billedeau SM et al. Liquid chromatography analysis of erythromycin A in salmon tissue by electrochemical detection with confirmation by electrospray ionization mass spectrometry. 2003 J. Agric. Food Chem. pmid:12617579
Al-Belasy FA and Hairam AR The efficacy of azithromycin in the treatment of acute infraorbital space infection. 2003 J. Oral Maxillofac. Surg. pmid:12618970
Bihr TP Protein-losing enteropathy caused by Lawsonia intracellularis in a weanling foal. 2003 Can. Vet. J. pmid:12619560
Sugita K et al. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori]. 2002 Jpn J Antibiot pmid:12621731
Schlünzen F et al. Structural basis for the antibiotic activity of ketolides and azalides. 2003 Structure pmid:12623020
Luber P et al. Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. 2003 J. Clin. Microbiol. pmid:12624030
Bartkus JM et al. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. 2003 J. Clin. Microbiol. pmid:12624047
Zampaloni C et al. emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. 2003 J. Clin. Microbiol. pmid:12624074
McCormick AW et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. 2003 Nat. Med. pmid:12627227
Enomoto F [Action mechanism of macrolide antibiotics in experimental otitis media]. 2001 Jpn J Antibiot pmid:12627603
Abe S et al. [Effects of 14-, 15-, and 16-membered ring macrolides on IL-8 gene expression in BET-1A cells]. 2001 Jpn J Antibiot pmid:12627606
Yamaryo T et al. [Effects of macrolide antibiotics on phagocytosis of apoptosis neutrophils by monocyte-derived macrophages]. 2001 Jpn J Antibiot pmid:12630388
SanFilippo A Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases. 1976 J. Pediatr. Surg. pmid:1263054
Rodriguez D and Davis MW The BEST study: results according to prior treatment. 2003 Cutis pmid:12630672
Holland DR and Quay JF Intestinal secretion of erythromycin base. 1976 J Pharm Sci pmid:1263092
Geraghty P and Kavanagh K Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans. 2003 J. Pharm. Pharmacol. pmid:12631409
Sanz Herrero F et al. [Pneumococcal pneumonia in hospitalized patients. Therapeutic implications of resistances to penicillin and erythromycin]. 2003 Med Clin (Barc) pmid:12636898
Abb J Comparative activity of linezolid, quinupristin-dalfopristin and newer quinolones against Streptococcus pneumoniae. 2003 Int. J. Antimicrob. Agents pmid:12636994
Rodeheffer MS and Shadel GS Multiple interactions involving the amino-terminal domain of yeast mtRNA polymerase determine the efficiency of mitochondrial protein synthesis. 2003 J. Biol. Chem. pmid:12637560
Nam C et al. Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents. 2003 Mar-Apr Skin Pharmacol. Appl. Skin Physiol. pmid:12637783
Oniscu C et al. [Methods of advanced purification-the challenge for biosynthetic antibiotics industry]. 2002 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:12638304
Jenett-Siems K et al. Ipobscurines C and D: macrolactam-type indole alkaloids from the seeds of Ipomoea obscura. 2003 Phytochemistry pmid:12648548
Lueger A et al. The influence of magnesium on the electrophysiological effects of erythromycin in the isolated Guinea pig heart. 2002 Cardiovasc Drugs Ther pmid:12652102
Ross JI et al. Antibiotic-resistant acne: lessons from Europe. 2003 Br. J. Dermatol. pmid:12653738
Lee H et al. Isolation of antibiotic hypersusceptibility mutants of Acinetobacter spp. by selection for DNA release. 2003 Antimicrob. Agents Chemother. pmid:12654657
Conejo Mdel C et al. Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest. 2003 Antimicrob. Agents Chemother. pmid:12654678
Ng LK et al. Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin? 2003 Antimicrob. Agents Chemother. pmid:12654699
Hammerschlag MR et al. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. 2003 J. Antimicrob. Chemother. pmid:12654764
Pardo Mateu L et al. [Laryngeal infection by Rhodococcus equi in patient with AIDS]. 2002 Acta Otorrinolaringol Esp pmid:12658846
Tsang KW et al. Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro. 2003 Eur. Respir. J. pmid:12661992
Cenedella RJ Beware of combining erythromycin with a statin. 2003 J Am Osteopath Assoc pmid:12665215
Al-Wabel NA et al. Electrocardiographic and hemodynamic effects of cisapride alone and combined with erythromycin in anesthetized dogs. 2002 Cardiovasc. Toxicol. pmid:12665665
Zachariadou L et al. Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children. 2003 Clin. Microbiol. Infect. pmid:12667242
Matsuoka M et al. Characteristic expression of three genes, msr(A), mph(C) and erm(Y), that confer resistance to macrolide antibiotics on Staphylococcus aureus. 2003 FEMS Microbiol. Lett. pmid:12670694
Shurin PA Antibacterial therapy and middle ear effusions. 1976 Mar-Apr Ann. Otol. Rhinol. Laryngol. pmid:1267355
Sutter VL and Finegold SM Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. 1976 Antimicrob. Agents Chemother. pmid:1267432
Kafali H et al. Management of non-neoplastic ovarian cysts with sclerotherapy. 2003 Int J Gynaecol Obstet pmid:12676392
Suchitra AD et al. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice. 2003 World J. Gastroenterol. pmid:12679931
Delforge M et al. Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes. 2003 Leuk. Res. pmid:12681358
Cooper KJ et al. The effect of erythromycin on the pharmacokinetics of rosuvastatin. 2003 Eur. J. Clin. Pharmacol. pmid:12682802
Clark-Price SC et al. Osteomyelitis of the pelvis caused by Rhodococcus equi in a two-year-old horse. 2003 J. Am. Vet. Med. Assoc. pmid:12685788
Tan HH Antibacterial therapy for acne: a guide to selection and use of systemic agents. 2003 Am J Clin Dermatol pmid:12688836
Chatzipanagiotou S et al. Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from Greece. 2003 Clin. Microbiol. Infect. pmid:12691547
Narasimhan R et al. Effect of erythromycin and cisapride on emptying of the vagally denervated intrathoracic stomach. 2002 Jul-Sep Trop Gastroenterol pmid:12693153
Nikkels AF et al. [Image of the month. Chancroid]. 2003 Rev Med Liege pmid:12693303
Rodriguez E et al. Rapid engineering of polyketide overproduction by gene transfer to industrially optimized strains. 2003 J. Ind. Microbiol. Biotechnol. pmid:12698320
Schwab D et al. Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. 2003 J. Med. Chem. pmid:12699389